Clotrimazol (cutaneous)

Generic name
Clotrimazol (cutaneous)
Brand name
ATC Code
D01AC01

Clotrimazol (cutaneous)

Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

Resorption: limited in intact skin (< 2%).

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Fungal infections of the skin
  • Cutaneous
    • 1 month up to 18 years
      • Apply twice a day to the affected skin

      • Duration of treatment:

        For at least 3-4 weeks. Continue treatment for at least one more week after symptoms disappear

Renal impaiment in children > 3 months

GFR ≥10 ml/min/1.73m2: Dose adjustment not required.

GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions in children

In case of diaper dermatitis, do not clean the affected skin with scented soap or wet wipes. Expose the diaper area to the air as much as possible.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

ANTIFUNGALS FOR TOPICAL USE

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

Antibiotics
D01AA01
Imidazole and triazole derivatives
D01AC08
D01AC02
D01AC20
D01AC09
Other antifungals for topical use
D01AE14
D01AE13
D01AE15
IMIDAZOLE AND TRIAZOLE DERIVATIVES
D01AC08
D01AC02
D01AC20
D01AC09
OTHER ANTIFUNGALS FOR TOPICAL USE
D01AE14
D01AE13
D01AE15

References

  1. KNMP, Zelfzorgstandaard voetschimmel, 2020
  2. Laboratoires Bailleul S.A., SmPC Imazol® Paste, 10mg/g Paste zur Anwendung auf der Haut (49764.00.00), 06/2017

Changes

Therapeutic Drug Monitoring


Overdose